Hemophilia: Molecular diagnosis and alternatives of treatment
The haemophilia is a recessive disease tied to the X chromosome that generally men suffer. The genetic preimplantation diagnosis (GPD), the prenatal diagnosis and the molecular diagnosis of the mutations that cause haemophilia, are realized in isolated investigations (researches) in order to do prim...
- Autores:
- Tipo de recurso:
- Fecha de publicación:
- 2007
- Institución:
- Universidad del Rosario
- Repositorio:
- Repositorio EdocUR - U. Rosario
- Idioma:
- eng
- OAI Identifier:
- oai:repository.urosario.edu.co:10336/23717
- Acceso en línea:
- https://repository.urosario.edu.co/handle/10336/23717
- Palabra clave:
- Blood clotting factor 8
Blood clotting factor 9
Immunosuppressive agent
Parvovirus vector
Clinical trial
Diagnostic value
Drug efficacy
Fluorescence in situ hybridization
Gene mutation
Gene transfer
Genetic screening
Hemophilia
Hemophilia a
Hemophilia b
Heterozygote
Human
Immunoadsorption
Nonhuman
Plasmapheresis
Polymerase chain reaction
Prenatal diagnosis
Primary prevention
Promoter region
Quality of life
Review
Short tandem repeat
Single strand conformation polymorphism
Southern blotting
Stem cell transplantation
Unspecified side effect
Viral gene therapy
X chromosome
Genetics
Hemophilia
Therapy
- Rights
- License
- Abierto (Texto Completo)
id |
EDOCUR2_d538703259a233bab8b2881b61fb9614 |
---|---|
oai_identifier_str |
oai:repository.urosario.edu.co:10336/23717 |
network_acronym_str |
EDOCUR2 |
network_name_str |
Repositorio EdocUR - U. Rosario |
repository_id_str |
|
spelling |
0e66991c-dd7c-4191-b5e9-0d0933540ab6b3e502fe-cd92-4c25-b132-748b65e5040152094825600193318196002020-05-26T00:04:46Z2020-05-26T00:04:46Z2007The haemophilia is a recessive disease tied to the X chromosome that generally men suffer. The genetic preimplantation diagnosis (GPD), the prenatal diagnosis and the molecular diagnosis of the mutations that cause haemophilia, are realized in isolated investigations (researches) in order to do primary prevention, provide advise to the carriers of the disease and their families, which has allowed to bring to the world children free of this disease and also to improve the quality of life of the affected ones. The hopeful procedures in gene therapy (GT) have shown great effectiveness. The intention is to achieve the normal production of the protein which is absent or it is altered in the affected ones, but at the moment the tests carried out in human beings are stopped. Here are other alternate therapies that although are in phase of investigation, would allow to obtain a production of protein to long term and which have been developed thanks to the understanding of the molecular nature of the coagulation factors. © 2007 Corporación Editora Médica del Valle.application/pdf1657953401208322https://repository.urosario.edu.co/handle/10336/23717engUniversidad del Valle-Facultad de Salud315No. 3308Colombia MedicaVol. 38Colombia Medica, ISSN:16579534, 01208322, Vol.38, No.3 (2007); pp. 308-315https://www.scopus.com/inward/record.uri?eid=2-s2.0-34548670523&partnerID=40&md5=a0e174a80d66c541bd8a2f399674d233Abierto (Texto Completo)http://purl.org/coar/access_right/c_abf2instname:Universidad del Rosarioreponame:Repositorio Institucional EdocURBlood clotting factor 8Blood clotting factor 9Immunosuppressive agentParvovirus vectorClinical trialDiagnostic valueDrug efficacyFluorescence in situ hybridizationGene mutationGene transferGenetic screeningHemophiliaHemophilia aHemophilia bHeterozygoteHumanImmunoadsorptionNonhumanPlasmapheresisPolymerase chain reactionPrenatal diagnosisPrimary preventionPromoter regionQuality of lifeReviewShort tandem repeatSingle strand conformation polymorphismSouthern blottingStem cell transplantationUnspecified side effectViral gene therapyX chromosomeGeneticsHemophiliaTherapyHemophilia: Molecular diagnosis and alternatives of treatmentHemofilia: Diagnóstico molecular y alternativas de tratamientoarticleArtículohttp://purl.org/coar/version/c_970fb48d4fbd8a85http://purl.org/coar/resource_type/c_6501Bermeo S.M.Silva C.T.Fonseca Mendoza, Dora JanethRestrepo Fernández, Carlos Martín10336/23717oai:repository.urosario.edu.co:10336/237172022-05-02 07:37:16.645328https://repository.urosario.edu.coRepositorio institucional EdocURedocur@urosario.edu.co |
dc.title.spa.fl_str_mv |
Hemophilia: Molecular diagnosis and alternatives of treatment |
dc.title.TranslatedTitle.spa.fl_str_mv |
Hemofilia: Diagnóstico molecular y alternativas de tratamiento |
title |
Hemophilia: Molecular diagnosis and alternatives of treatment |
spellingShingle |
Hemophilia: Molecular diagnosis and alternatives of treatment Blood clotting factor 8 Blood clotting factor 9 Immunosuppressive agent Parvovirus vector Clinical trial Diagnostic value Drug efficacy Fluorescence in situ hybridization Gene mutation Gene transfer Genetic screening Hemophilia Hemophilia a Hemophilia b Heterozygote Human Immunoadsorption Nonhuman Plasmapheresis Polymerase chain reaction Prenatal diagnosis Primary prevention Promoter region Quality of life Review Short tandem repeat Single strand conformation polymorphism Southern blotting Stem cell transplantation Unspecified side effect Viral gene therapy X chromosome Genetics Hemophilia Therapy |
title_short |
Hemophilia: Molecular diagnosis and alternatives of treatment |
title_full |
Hemophilia: Molecular diagnosis and alternatives of treatment |
title_fullStr |
Hemophilia: Molecular diagnosis and alternatives of treatment |
title_full_unstemmed |
Hemophilia: Molecular diagnosis and alternatives of treatment |
title_sort |
Hemophilia: Molecular diagnosis and alternatives of treatment |
dc.subject.keyword.spa.fl_str_mv |
Blood clotting factor 8 Blood clotting factor 9 Immunosuppressive agent Parvovirus vector Clinical trial Diagnostic value Drug efficacy Fluorescence in situ hybridization Gene mutation Gene transfer Genetic screening Hemophilia Hemophilia a Hemophilia b Heterozygote Human Immunoadsorption Nonhuman Plasmapheresis Polymerase chain reaction Prenatal diagnosis Primary prevention Promoter region Quality of life Review Short tandem repeat Single strand conformation polymorphism Southern blotting Stem cell transplantation Unspecified side effect Viral gene therapy X chromosome Genetics Hemophilia Therapy |
topic |
Blood clotting factor 8 Blood clotting factor 9 Immunosuppressive agent Parvovirus vector Clinical trial Diagnostic value Drug efficacy Fluorescence in situ hybridization Gene mutation Gene transfer Genetic screening Hemophilia Hemophilia a Hemophilia b Heterozygote Human Immunoadsorption Nonhuman Plasmapheresis Polymerase chain reaction Prenatal diagnosis Primary prevention Promoter region Quality of life Review Short tandem repeat Single strand conformation polymorphism Southern blotting Stem cell transplantation Unspecified side effect Viral gene therapy X chromosome Genetics Hemophilia Therapy |
description |
The haemophilia is a recessive disease tied to the X chromosome that generally men suffer. The genetic preimplantation diagnosis (GPD), the prenatal diagnosis and the molecular diagnosis of the mutations that cause haemophilia, are realized in isolated investigations (researches) in order to do primary prevention, provide advise to the carriers of the disease and their families, which has allowed to bring to the world children free of this disease and also to improve the quality of life of the affected ones. The hopeful procedures in gene therapy (GT) have shown great effectiveness. The intention is to achieve the normal production of the protein which is absent or it is altered in the affected ones, but at the moment the tests carried out in human beings are stopped. Here are other alternate therapies that although are in phase of investigation, would allow to obtain a production of protein to long term and which have been developed thanks to the understanding of the molecular nature of the coagulation factors. © 2007 Corporación Editora Médica del Valle. |
publishDate |
2007 |
dc.date.created.spa.fl_str_mv |
2007 |
dc.date.accessioned.none.fl_str_mv |
2020-05-26T00:04:46Z |
dc.date.available.none.fl_str_mv |
2020-05-26T00:04:46Z |
dc.type.eng.fl_str_mv |
article |
dc.type.coarversion.fl_str_mv |
http://purl.org/coar/version/c_970fb48d4fbd8a85 |
dc.type.coar.fl_str_mv |
http://purl.org/coar/resource_type/c_6501 |
dc.type.spa.spa.fl_str_mv |
Artículo |
dc.identifier.issn.none.fl_str_mv |
16579534 01208322 |
dc.identifier.uri.none.fl_str_mv |
https://repository.urosario.edu.co/handle/10336/23717 |
identifier_str_mv |
16579534 01208322 |
url |
https://repository.urosario.edu.co/handle/10336/23717 |
dc.language.iso.spa.fl_str_mv |
eng |
language |
eng |
dc.relation.citationEndPage.none.fl_str_mv |
315 |
dc.relation.citationIssue.none.fl_str_mv |
No. 3 |
dc.relation.citationStartPage.none.fl_str_mv |
308 |
dc.relation.citationTitle.none.fl_str_mv |
Colombia Medica |
dc.relation.citationVolume.none.fl_str_mv |
Vol. 38 |
dc.relation.ispartof.spa.fl_str_mv |
Colombia Medica, ISSN:16579534, 01208322, Vol.38, No.3 (2007); pp. 308-315 |
dc.relation.uri.spa.fl_str_mv |
https://www.scopus.com/inward/record.uri?eid=2-s2.0-34548670523&partnerID=40&md5=a0e174a80d66c541bd8a2f399674d233 |
dc.rights.coar.fl_str_mv |
http://purl.org/coar/access_right/c_abf2 |
dc.rights.acceso.spa.fl_str_mv |
Abierto (Texto Completo) |
rights_invalid_str_mv |
Abierto (Texto Completo) http://purl.org/coar/access_right/c_abf2 |
dc.format.mimetype.none.fl_str_mv |
application/pdf |
dc.publisher.spa.fl_str_mv |
Universidad del Valle-Facultad de Salud |
institution |
Universidad del Rosario |
dc.source.instname.spa.fl_str_mv |
instname:Universidad del Rosario |
dc.source.reponame.spa.fl_str_mv |
reponame:Repositorio Institucional EdocUR |
repository.name.fl_str_mv |
Repositorio institucional EdocUR |
repository.mail.fl_str_mv |
edocur@urosario.edu.co |
_version_ |
1814167739723415552 |